Gene Query: TFDP1

Dataset Description Geneva Score
Effect of 48h treatment with 100nM GSK2879552 on T-ALL cell lines LOUCY and PEER 80.05
GREB1, a novel target of Wnt signaling, promotes development of hepatoblastoma by suppressing TGFβ signaling 57.72
The regulartory role of ZCCHC24 in splicing machinery 53.17
MicroRNA-mediated suppression of the TGF-β pathway confers transmissible and reversible CDK4/6 inhibitor resistance 41.27
MicroRNA-mediated suppression of the TGF-β pathway confers transmissible and reversible CDK4/6 inhibitor resistance (RNA-Seq) 41.27
MYCi361 regulates MYC target genes 41.23
Control of prostate tumour growth by the long non-coding RNA GHSROS 33.29
RNA-Seq analysis of 4N and 2N RPE1 cells following polyploid induction via cytokinesis failure by siRNA knockdown of Anillin [tpo8] 33.18
COMBINING BET AND MEK INHIBITORS SYNERGISTICALLY TARGETS NRAS MUTANT MELANOMA 33.17
Region-specific Innate Antiviral Responses of the Human Epididymis 30.1
Lineage tracing of acute myeloid leukemia reveals the impact of hypomethylating agents on chemoresistance selection 29.95
Combined inhibition of STAT3 and DNA repair in palbociclib-resistant ER-positive breast cancer 29.52
Adaptive chromatin remodeling in glioblastoma stem cell plasticity and drug tolerance 29.32
Nudt3 is a mRNA Decapping Enzyme That Modulates Cell Migration 28.51
RNAseq of T-ALL upon long non coding rna purturbation 28.15
Gene expression profile of LMSU gastric cancer cell p53 KO and KD 27.58
Transcriptional profiles of normal human mature B cells 27.32
Tristetraprolin disables prostate cancer maintenance by impairing proliferation and metabolic function 27.31
Genetic disruption of COX-1 inhibits multiple oncogenic pathways 26.5
Global analysis of ZNF217 chromatin occupancy in the breast cancer cell genome reveals an association with Eralpha 25.27
CBFb-SMMHC inhibition triggers apoptosis by disrupting MYC chromatin dynamics in acute myeloid leukemia [RNA-seq] 24.78
CBFb-SMMHC inhibition triggers apoptosis by disrupting MYC chromatin dynamics in acute myeloid leukemia 24.78
Identification of ZEB1-regulated gene expression changes in HCC827 human lung adenocarcinoma cells 24.65
SPOP mutation confers intrinsic BET inhibitor resistance in prostate cancer (BRD4_JQ1_RNA-seq) 24.3
RNA-seq of resting and activated CD4+ T cells +-JQ1 23.5
SIX4 acts as a master regulator of genes associated with the malignant phenotype of non-small cell lung cancer cells 23.48
MUC1-C represses the RASSF1A tumor suppressor and activated Kras signaling in human carcinoma cells 23.27
Next Generation Sequencing and m6A sequencing Facilitates Quantitative Analysis of Wild Type and genetic FTO knockdown ccRCC cells Transcriptomes 22.74
Next generation sequencing on knockdown of AC093323.3 in lung cancer cells 22.21
A cytoplasmic COMPASS is necessary for cell survival and triple-negative breast cancer pathogenesis by regulating metabolism 22.13
Uridilation by TUT4/7 restricts retrotransposition of human Line-1s 22.1
Transcript abundance in A-T-derived iPSC: Comparing isogenic cells to unrelated individual 21.76
Overexpression of UGT2B17 in MEC1 and JVM2 leukemia cell lines 21.54
miRNA-1343 attenuates pathways of fibrosis by targeting the TGF-beta receptors [RNA-seq] 21.15
Hit-and-run' programing of CAR-T cells using mRNA nanocarriers 21.02
Wnt addiction of genetically defined cancers reversed by PORCN inhibition 20.45
Single Cell RNA-Sequencing Identifies Diverse Roles of Epithelial Cells in Idiopathic Pulmonary Fibrosis 20.41
Clinker: visualizing fusion genes detected in RNA-seq data 20.36
Metabolic reprogramming of Kaposi’s sarcoma associated herpes virus infected B-cells in hypoxia 19.97
mRNA expression profiling in MDA-MB-231 (LM1) cells with a tet-incible MBD2 or p66α knock down, or treated with MBD2-targeting small molecule ABA or APC 19.88
Che-1 is targeted by c-Myc to sustain proliferation in pre-B-cell acute lymphoblastic leukemia [RNA-seq] 19.87
Che-1 is targeted by c-Myc to sustain proliferation in pre-B-cell acute lymphoblastic leukemia 19.87
Evidence for HOXC6 as a potential molecular marker for non-small cell lung cancer 19.73
Recruiting Endogenous ADARs with Antisense Oligonucleotides to Reprogram the Transcriptome 19.61
HuR controls apoptosis and activation response without effects on cytokine 3′ UTRs 19.38
RNA-seq Transcriptome Analysis of AD169 and AD169-ΔUL26 infected MRC5 fibroblasts. 19.28
Supraphysiological Androgens Repress Prostate Cancer Growth and Induce DNA Damage Augmented by PARP Inhibition 19.26
Global analysis of pre-mRNA subcellular localization upon splicing inhibition by spliceostatin A 19.15
Modeling the MYC-driven normal-to-tumour switch in breast cancer. 18.93
NRDE2 negatively regulates nuclear exosome functions 18.61
ncRNA (non-coding RNA) signature in endothelial cells during hypoxia 18.42
ncRNA (non-coding RNA) signature in endothelial cells during hypoxia [RNA-seq] 18.42
The Adenovirus E1A C Terminus Suppresses a Delayed Antiviral Response and Modulates RAS Signaling 18.37
The Adenovirus E1A C Terminus Suppresses a Delayed Antiviral Response and Modulates RAS Signaling [RNA-seq] 18.37
A novel P300 inhibitor reverses DUX4-mediated global histone H3 hyperacetylation, target gene expression and cell death 18.35
Genome-wide CRISPR-Cas9 screen identifies druggable synthetic lethality between LSD1 and MTORC1 in MLL-translocated AML 18.28
Cleavage Factor Im as a key regulator of 3’ UTR length 18.23
Axitinib exposure triggers endothelial cells senescence through ROS accumulation and ATM activation 18.23
MenSCs inhibit HCC growth through oncogenic pathway suppression via regulating 5-hmC in enhancer elements 18.08
MenSCs inhibit HCC growth through oncogenic pathway suppression via regulating 5-hmC in enhancer elements [RNA-seq] 18.08
Identification of global regulators of T-helper cell lineage specification 17.91
Identification of global regulators of T-helper cell lineage specification (RNA-Seq) 17.91
Gene expression profiles of primary human NK cells before and after expansion on CSTX002 feeder cells, with and without IL-21 stimulation 17.91
Effect of FGF13 depletion on the H460 cell line 17.91
Benzotriazoles reactivate latent HIV-1 through inactivation of STAT5 SUMOylation (RNA-Seq) 17.78
Benzotriazoles reactivate latent HIV-1 through inactivation of STAT5 SUMOylation 17.78
Knockdown of ADNP in HCT116 colon cancer cells 17.76
GCTM-5 positive and negative cells in pancreatic adenocarcinoma cell lines 17.64
Co-regulation of splicing by Rbfox1 and hnRNP M [hnRNPM k-d+Rbfox1 RNA-Seq] 17.44
Co-regulation of splicing by Rbfox1 and hnRNP M 17.44
RNA-sequencing of isogenic primary, pre-malignant immortalized, and Ras-transformed human mammary epithelial cells 17.28
HDAC inhibition enhances the in vivo efficacy of MEK inhibitor therapy in uveal melanoma 17.22
Integrative analysis identifies lincRNAs up- and downstream of neuroblastoma driver genes (ALK) 17.19
Identifying the molecular mode of action of itraconazole in colorectal cancer 17.18
Acetylation-Dependent Control of Global Poly(A) RNA Degradation by CBP/p300 and HDAC1/2 17.03
Gene expression analysis of dengue-infected cells 16.96
Transcriptomic analysis of healthy donor and Sickle Cell Disease (SCD) hematopoietic stem/progenitor cells 16.64
Gene expression comparison of resting human peripheral-blood NK cells and activated counterparts 16.62
Landscape of H3K4me3 in human CD19 cells 16.61
A novel lncRNA lncRNA-AK096729 promotes colorectal carcinogenesis and glucose metabolism by stabilizing and specifying the transcription modification pattern of c-Myc 16.49
DHX9 suppresses spurious RNA processing defects originating from the Alu invasion of the human genome [uvCLAP CLIP-seq] 16.47
Widespread intronic polyadenylation diversifies immune cell transcriptomes 16.44
MYC dependent mRNA translation shapes gene expression and cell biology 16.31
HIV-1 perturbs homeostatic ILCs, unmasks ILC1 plasticity, and boosts TCF7+ memory NK cells 16.2
UBR7 is a novel E3 ubiquitin ligase for H2BK120 and acts as a tumor-suppressor in breast cancer [RNA-Seq] 15.96
UBR7 is a novel E3 ubiquitin ligase for H2BK120 and acts as a tumor-suppressor in breast cancer 15.96
Transcriptomic analysis of T84 colon carcinoma cell line treated with trametinib, JQ1 or their combination 15.83
RNA seq data of Hep3B-control, Hep3B-sertraline, Hep3B-XL413, Hep3B-XL413-sertraline, Huh7-control, Huh7-sertraline, Huh7-XL413, Huh7-XL413-sertraline cells 15.78
RNA transcriptome analysis during HSV-1 infection 15.69
Genome wide expression change by RNF168 knocking down in MCF-7 cells 15.56
Activation of a SOX2-dependent transcriptional regulatory circuit drives glioblastoma. 15.56
A comprehensive single cell transcriptional landscape of human hematopoietic progenitors 15.56
mRNA-sequencing of U87 glioblastoma and DAOY medulloblastoma spheroidal aggregates undergoing electrotaxis 15.33
Leukodystrophy-associated POLR3A mutations down-regulate the RNA polymerase III transcript and important regulatory RNA BC200 15.31
The LIN28B/let-7 axis is a novel therapeutic pathway in Multiple Myeloma 15.17
Transcriptomic profiles of human foreskin fibroblast cells in response to orf virus 14.93
RNA-sequencing of human mammary epithelial cells (HMLEs) engineered to express either ER or ER-SOX4 with and without 4-OHT to induce nuclear translocation 14.91
Implication of Long noncoding RNAs in the endothelial cell response to hypoxia revealed by RNA-sequencing. 14.91
Presence of NAD+-capped RNA in human cells: function and removal by the DXO deNADing Protein 14.83
Sensing self and nonself circular RNAs 14.71
BRG1 governs Glucocorticoid Receptor interactions with chromatin and pioneer factors across the genome 14.69
RNA-seq in SUNE-1 cells after downregulation of DANCR expression 14.64
Ribosome profiling of A549 cells depleted of RPLP1 and RPLP2 and infected with DENV. 14.63
Differential gene expression tools exhibit substandard performance for long non-coding RNA-sequencing data 14.61
Enhancing human kidney organoid differentiation from pluripotent stem cells with high-throughput automation 14.6
Analysis of Th17 gene signature in the presence of CD28 costimulation in human CD4 naïve T cells 14.6
HEK293 TFAM Knockout Expression Study 14.55
Dynamic gene regulatory networks of human myeloid differentiation [RNA-seq_siRNA] 14.54
Activation of Wnt/beta-catenin in Ewing sarcoma cells antagonizes EWS/ETS function and promotes phenotypic transition to more metastatic cell states 14.37
Effects of Belinostat and Dexamethasone treatment of A549 gene expression 14.18
Global transcriptional changes in U87MG glioblastoma cells upon shRNA-mediated TRIM52 knockdown 14.14
Pancreatic cancer-derived exosomes induce apoptosis of T lymphocytes through the p38 MAPK signal transduction pathway 14.03
RNA-seq analysis of YFV-17D specific and total naive CD8 T cells in humans 13.95
Expression profile of Lo19S state cells in the presence and absence of bortezomib treatment 13.88
Identification of Sin3B regulated genes during quiescence 13.82
mRNA-sequencing of 293T-no dice transfected with miR-16, miR-214, or KSHV-miR-K6-5p 13.76
RNA sequencing of HepG2 cells treated with estradiol or estrogen receptor agonist 13.75
A Surveillance System of Active Enhancers by a RACK7-histone Demethylase Complex 13.46
PHF20 readers link methylation of histone H3K4 and p53 with H4K16 acetylation 13.45
Transcriptome analysis on TDP43 and SRSF3 downstream genes and binding RNAs in MDA-MB231 cells by Next Generation Sequencing 13.44
Overexpression and knockdown experiment for circCSNK1G3 13.36
Antibodies That Convert Bone Marrow Into Trafficking Microglia-Like Cells Reduce Brain Amyloid 13.34
Epigenomic landscape during organ formation in human early embryos 13.33
CTCF and CohesinSA-1 Mark Active Promoters and Boundaries of Repressive Chromatin Domains in Primary Human Erythroid Cells [RNA-Seq] 13.25
CTCF and CohesinSA-1 Mark Active Promoters and Boundaries of Repressive Chromatin Domains in Primary Human Erythroid Cells 13.25
Transcriptomic profiling of HeLa cells infected with Salmonella Typhimurium 13.24
RNA-seq of young and quiescent MRC-5 human fibroblasts 13.2
Characterization of transcriptomics landscape in HUVEC cells exposed to oxidative stress 13.2
Transcriptome analysis of immature and matured human oocytes from patients of young and advanced maternal age 13.19
Inhibition of TAZ contributes radiation-induced senescence and growth arrest in glioma cells 13.05
Genome-wide Analysis of Human Constitutive Androstane Receptor (CAR) Transcriptome in Wild-type and CAR-knockout HepaRG cells 12.99
RNA-seq analyses of human prostate cancer cells 12.96
Wnt5a and its downstream transcription factor Stat3 are therapeutic targets for diffuse intrinsic pontine gliomas 12.89
Differential expression of human parthenogenic stem cells, neural stem cells and DA progenitors. 12.77
Genistein and bisphenol A exposure cause estrogen receptor 1 to bind thousands of binding sites in a cell type-specific manner 12.76
Mechanistic Model-Guided Study of Embryonic Morphogenesis 12.74
Bromodomain protein BRD4 is a transcriptional repressor of autophagy and lysosomal function 12.7
Characterization of parental and rociletinib-resistant derived H1975 cell lines 12.63
LINE-1 elements are derepressed in senescent cells and elicit a chronic Type-I Interferon response 12.49
Human Nonsense-Mediated RNA Decay Initiates Widely by Endonucleolysis and Targets snoRNA Host Genes 12.35
Human Adipocytes Regulate Gene Expression in Triple-negative Breast Cancer Assessed by NGS Sequencing 12.35
Genome-wide CRISPR-Cas9 screen identifies functionally relevant microRNAs in AML 12.33
Expression profile of wild type (WT) vs miR-155-/- in FLT3-ITD+ AML (MV4-11) cell lines 12.33
3’ Uridylation Expands miRNA Target Repertoire 12.3
Gene expression changes upon drug withdrawal (A375/451Lu cell lines) 12.28
Involvement of Condensin in Cellular Senescence through Gene Regulation and Compartmental Reorganization 12.25
Widespread N6-methyladenosine-dependent RNA Structural Switches Regulate RNA-Protein Interactions 12.21
Genome-wide maps in MCF-7 cells with six2 or CYP4Z1 3'UTR or CYP4Z2P 3'UTR overexpression or not 12.2
Detection of internal N7-methylguanosine (m7G) RNA modifications by mutational profiling sequencing 12.2
Gene expression regulated by CSA and CSB in neuroblastoma cell line 12.18
Hijacking of stress response machinery by oncogenes in acute leukaemia [RNA-seq] 12.15
Hijacking of stress response machinery by oncogenes in acute leukaemia 12.15
A compendium of promoter-centered long-range chromatin interactions in diverse human tissues and cell types 12.13
RNA-Seq analysis RPE1 cells following exposure to Nutlin-3 to identify target genes of p53 [tpo12] 12.02
Differential gene expression in Jagged1 treated human dental pulp cells. 11.98
JQ1 +/- Vemurafenib in BRAF mutant melanoma (A375) 11.95
hnRNP C is a key regulator of protein synthesis in mitosis 11.95
A code of mono-phosphorylation modulates the function of RB. 11.88
Whole-Transcriptome Profiling of Canine and Human in Vitro Models Exposed to a G-Quadruplex Binding Small Molecule 11.85
Respecifying human iPSC-derived blood cells into highly engraftable hematopoietic stem and progenitor cells with a single factor 11.83
Transcriptome-wide analysis of the role of HTLV-1 Tax PBM in T-Cells from infected humanized-mice (hu-Mice) 11.73
The role of PHF19 in promoting H3K27me3 deposition in multiple myeloma 11.72
The role of PHF19 in promoting H3K27me3 deposition in multiple myeloma (RNA-Seq) 11.72
Gene expression data from IMR90 control, IMR90 shRRM2 and shRRM2/shp16 11.71
The histone H3.3K36M mutation reprograms the epigenome of chondroblastomas 11.68
HNRNPM-regulated splicing dependencies in prostate cancer [RNA-Seq] 11.65
HNRNPM-regulated splicing dependencies in prostate cancer 11.65
Proliferation pause as an early blockade of human cellular reprogramming toward pluripotency [RNA-seq analysis] 11.62
Thymine DNA Glycosylase as a novel target for melanoma: effect of TDG silencing on gene expression in SK-mel-28 melanoma cells 11.48
High-throughput RNA sequencing on circular RNA profiles of human pancreatic cancer cell lines and gemcitabine resistant pancreatic cancer cell lines. 11.48
Proteostasis by STUB1/HSP70 complex controls sensitivity to androgen receptor targeted therapy in advanced prostate cancer 11.45
Proteostasis by STUB1/HSP70 complex controls sensitivity to androgen receptor targeted therapy in advanced prostate cancer (RNA-Seq) 11.45
mRNA expression profile of Lymphocytes 11.35
Comparative whole-transcriptomic analysis between normal and AKAP-Lbc-depleted human embryonic stem cells 11.34
RNA-sequencing of human peripheral blood mononuclear cells (PB MNCs) and induced neural progenitor cells derived from PB MNCs 11.27
Integrative transcriptome-wide analyses reveal critical HER2-regulated mRNAs and lincRNAs in HER2+ breast cancer 11.23
Pericyte-like cells generated from human pluripotent stem cells support hematopoietic stem and progenitors ex vivo 11.22
Complementary Post Transcriptional Regulatory Information is Detected by PUNCH-P and Ribosome Profiling 11.21
Role of XRN2 ribonucleolytic activity in RNA metabolism 11.11
Specific labeling of stem cell activity in human colorectal organoids using an ASCL2-responsive minigene 11.09
WNK1 kinase and the termination factor PCF11 connect nuclear mRNA export with transcription 11.06
Assessing the effect of SUPT4H1 RNAi on the transcription of a repeat-containing reporter construct 11.01
Next Generation Sequencing Facilitates Quantitative Analysis of HIV-1 Latency in Central Memory T Cells 11.01
Epigenome-wide Effects of Vitamin-D on Bronchial Epithelial Cells using ATAC-Seq and RNA-seq 10.99
Genome-wide functional assessment of enhancer activities in the human genome 10.98
Alarmin S100A11 initiates a chemokine response to the human pathogen Toxoplasma gondii 10.94
Adaptive resistance of melanoma cells to RAF inhibition via reversible induction of a slowly-dividing de-differentiated state 10.94
Short and Long RNA sequencing of human mature erythrocytes 10.9
RNA expression in primary huamn muscle cells treated with 1,25(OH)2D3 or vehicle 10.9
mRNA and miRNA expression in primary human muscle cells treated with 1,25(OH)2D3 or vehicle 10.9
Differential roles of human PUS10 in miRNA processing and tRNA pseudouridylation 10.9
Polycomb- and Methylation-Independent Roles of EZH2 as a Transcription Activator 10.87
Polycomb- and Methylation-Independent Roles of EZH2 as a Transcription Activator [RNA-seq] 10.87
RNAseq analysis of patient-derived luminal breast cancer xenografts treated with progestins 10.85
Patient-derived luminal breast cancer xenografts with progestins 10.85
Gene expression changes caused by KRAS in MCF-10A 10.8
Expression profiles of restoration of BAP1 in a BAP1 deficient cell line 10.79
Transcriptome analysis of BAP1 knockout and restoration 10.79
Combined use of astragalus polysaccharide and berberine attenuates insulin resistance in IR-HepG2 cells via regulation of the gluconeogenesis signaling pathway 10.77
Culture-induced recurrent epigenetic aberrations in human pluripotent stem cells [RNA-seq] 10.76
Culture-induced recurrent epigenetic aberrations in human pluripotent stem cells 10.76
Hydrogel scaffolds promote neural gene expression and structural reorganization in human astrocyte cultures 10.76
Endothelial gene expression analysis 10.72
Total RNA deep sequencing (ribosomal depleted) of human umbilical vein endothelial cells exposed to hypoxia (0.2%) for 12h and 24h or kept under normoxic conditions. 10.72
RNA-seq of YB5 and MCF7 treated with different doses of decitabine 10.67
Single-cell transcriptomics of the human placenta: inferring the cell communication network of the maternal-fetal interface 10.64
Targeted Apoptosis of Senescent Cells Restores Tissue Homeostasis in Response to Chemotoxicity and Aging 10.59
RNA-seq of human foreskin fibroblast cells lacking RB and/or p130 after doxorubicin treatment 10.58
Ex-vivo Human Hematopoietic Stem Cell Expansion Requires Coordination of Cellular Reprogramming with Mitochondrial Remodeling and P53 Activation [bulk] 10.54
Effect of 48h treatment with 100nM GSK2879552 on T-ALL cell lines HSB2 and RPMI8402 10.54
Tracking of dCas9-methyltransferase footprints 10.51
Poly(A)-ClickSeq resolves CF25-mediated alternative poly-adenylation, HeLa 10.38
Transcriptomic Reprogramming of Prostate Cancer Cells Driven by Stroma-Derived SPINK1 10.34
Campylobacter concisus pathotypes induce distinct global responses in intestinal epithelial cells [BAA] 10.32
Differential expression of long non‑coding RNA and mRNA in children with Henoch‑Schönlein purpura nephritis 10.31
Organoids derived from directly reprogrammed human hepatocytes for modeling liver cancer initiation 10.3
RNA G-quadruplexes cause eIF4A-dependent oncogene translation in cancer 10.3
Agonistic targeting of TLR1/TLR2 induces p38 MAPK-dependent apoptosis and NfkB-dependent differentiation of AML cells 10.26
Cyclophosphamide (CTX) Enhances Cancer Antibody Immunotherapy in the Resistant Bone Marrow Niche by Modulating Macrophage FcγR Expression 10.22
TNF response in promyelocytic and granulocytic forms of HL60/S4 cells 10.21
Mitochondrial dsRNA triggers antiviral signalling in humans 10.21
Lipid catabolism inhibition sensitizes prostate cancer cells to antiandrogen blockade 10.2
NR2F2 study 10.11
Estrogen response in breast cancer cell line MCF-7 is dependent on NR2F2 [RNA-seq] 10.11
shRNA knockdown of YAP1 in HCC364 cells, various drug conditions 10.1
Transcriptome analysis of CNS leukemia 10.08
RNA-seq analysis of primary patient samples to characterize the CNS leukemia 10.08
Gene expression profile of HGC27 and LMSU gastric cancer cell p53 KO and KD 10.06
Transcriptome-profiling (RNA-seq) and Ribosome-profiling (Ribo-seq) of BJ cells treated with Nutlin-3a, an MDM2 inhibitor, which induces p53. 10.05
Pluripotent stem cell model of Nakajo-Nishimura syndrome untangles proinflammatory pathways mediated by oxidative stress 10.02
Role of BET proteins in YAP/TAZ-dependent transcription [RNA-seq 1] 10.0
Role of microRNAs in the interaction between Salmonella and the host cell 9.97
RNA-seq of naive and primed ES cells (NHSM) 9.97
DHX15 regulates CMTR1-dependent gene expression and cell proliferation 9.96
The X-linked DDX3X RNA helicase dictates translation re-programming and metastasis in melanoma 9.95
Nrf2 regulated genes in A549 cells 9.78
Identification of Nrf2 regulated genes by RNA sequencing 9.78
HBEC-shp53-PCHD7 9.72
Sequencing of matched pair samples (diagnosis and relapse) in human B-cell acute lymphoblastic leukemia cells (ALL) 9.7
Reassessment of Exosome Composition 9.68
Next Generation Sequencing Facilitates Quantitative Analysis of ALDH+ E-BCSC, CD24-CD44+ M-BCSC and Bulk tumor cell Transcriptomes from MC1 and Vari068 PDX models of TNBC 9.68
Rare cell variability and drug-induced reprogramming as a mode of cancer drug resistance [RNA-seq] 9.66
Identification of differential expressed genes of JQ1 or JQ1+Bortezomib in colorectal cancer cells 9.66
RNA-seq analysis of umbilical cord blood cells upon knockdown of NAP1L3 9.65
Cellular acidosis triggers MondoA transcriptional activity by driving mitochondrial ATP production 9.64
Tumor hypoxia causes DNA hypermethylation by reducing TET activity (RNA-Seq) 9.61
Tumor hypoxia causes DNA hypermethylation by reducing TET activity 9.61
Base-resolution mapping reveals distinct classes of N1-methyladenosine methylome in nuclear- and mitochondrial-encoded transcripts 9.6
Transcriptomic analysis of the HOTAIR-regulated genes 9.57
SNHG5 siRNA knock down in HCT116 cells 9.56
Gene expression, methylome and splicing of THP-1 monocytic cells and THP-1-derived macrophage 9.48
Expression profile of HNF1A knockdown and overexpression in 22RV1 and LNCaP cells respectively 9.42
CD95L derived si- and shRNAs and the CD95L mRNA kill cancer cells through an RNAi mechanism by targeting survival genes [siL3.RNAseq.lg] 9.4
Folliculin regulates mTORC1/2 and WNT pathways in early human pluripotency 9.36
Comparison of small cell lung cancer PDX model FHSC04 for response to LSD1 inhibitor RG6016/ORY1001 9.35
Cooperation of GRSF1 and the mitochondrial degradosome (hSuv3-PNPase complex) in degradation of mitochondrial RNA 9.33
Estrogen deprivation triggers and immunosuppressive phenotype in breast cancer cells 9.33
Limiting cholesterol biosynthetic flux engages type I IFN signaling in a STING-dependent manner 9.27
Reversible LSD1 Inhibition with HCI-2509 induces the p53 gene expression signature in high-risk neuroblastoma cells 9.23
Global transcriptional analysis of human extended pluripotent stem cells, human primed pluripotent stem cells, mouse extended pluripotent stem cells, and mouse embryonic stem cells by RNA-seq 9.22
Global transcriptional analysis and genome-wide analysis of chromatin state in extended pluripotent stem cells, primed pluripotent stem cells, and naïve pluripotent stem cells 9.22
Indoxyl sulfate stimulates angiogenesis by regulating reactive oxygen species production via CYP1B1 9.22
Genome-wide maps of m6A circRNAs identify widespread and cell-type-specific methylation patterns that are distinct from mRNAs 9.19
Transcriptional impact of MTHFD2 in Human Aortic Endothelial Cells 9.17
Convergent exaptation of Alu and B/ID SINEs for Staufen-mediated mRNA decay 9.1
Gene induction by the USP6 oncogene in response to interferon 9.1
Endogenous retroviruses are a source of oncogenic enhancers in acute myeloid leukemia 9.09
Endogenous retroviruses are a source of oncogenic enhancers in acute myeloid leukemia [RNA-Seq] 9.09
Genetic disarray follows mutant KLF1-E325K expression in a congenital dyserythropoietic anemia patient 9.08
RNA-seq of H1299 cells in which either PRKCI or SOX2 was silenced by validated lentiviral shRNA constructs 9.07
Dioxin and AHR impairs mesoderm gene expression and cardiac differentiation in human embryonic stem cells (RNA-Seq) 9.06
Dioxin and AHR impairs mesoderm gene expression and cardiac differentiation in human embryonic stem cells 9.06
RNA-Seq comparative analysis of human neuroblastoma cells before and after their confrontation to the embryonic microenvironment 8.95
Rorc disruption in human FG pancreatic cancer cells 8.95
Epigenetic siRNA and chemical screens identify SETD8 inhibition as a new therapeutic strategy of p53 reactivation in high-risk Neuroblastoma. 8.82
MCF10A H-Ras RNA-Seq 8.81
A recessive form of hyper-IgE syndrome by disruption of ZNF341-dependent STAT3 transcription and activity 8.76
Subcellular RNA fractions of HSV-1 infected primary human fibroblasts 8.69
AML subtype is a major determinant of the association between prognostic gene expression signatures and their clinical significance. 8.68
RNAi profiling of primary human AML cells identifies ROCK1 as a therapeutic target and nominates Fasudil as an anti-leukemic drug. 8.63
Transcriptomic profiling discloses molecular and cellular events related to neuronal differentiation in SH-SY5Y cells 8.57
Modulation of SF3B1 causes global intron retention and downregulation of the B-cell receptor pathway in chronic lymphocytic leukemia 8.54
The SUMO Pathway as a Therapeutic Option in Pancreatic Cancer 8.52
Gene expressions of H9s in different culture systems 8.51
Biosynthesis of histone messenger RNA employs a specific 3' end endonuclease 8.51
RUNX1-ETO and RUNX1-EVI-1 differentially program the chromatin landscape in t(3;21) and t(8;21) AML but share global C/EBP-alpha dysfunction 8.5
RUNX1-ETO and RUNX1-EVI-1 differentially program the chromatin landscape in t(3;21) and t(8;21) AML but share global C/EBP-alpha dysfunction (RNA-Seq) 8.5
RNA-seq analysis of RALD iPSCs after in vitro differentiation 8.49
Differential Protein Occupancy Profiling of the mRNA Transcriptome 8.45
Gene expression analysis of C4-2 cells treated with ACLY inhibitor and Enzalutamide 8.42
Genome-wide transcriptional response to random aneuploidy in human cells 8.41
MKL1 augments megakaryocyte maturation by enhancing the SRF regulatory axis 8.33
MKL1 augments megakaryocyte maturation by enhancing the SRF regulatory axis [RNA-seq] 8.33
Dynamic 3D chromosomal landscapes in acute leukemia 8.33
Dynamic 3D chromosomal landscapes in acute leukemia [RNA-Seq] 8.33
Gene expression and 4sUDRB-seq for NF90/NF110 of human scramble and KD HeLa cells. 8.17
RNA-Seq analysis and comparison of corneal epithelium in keratoconus and myopia patients 8.17
Unique features and clinical importance of acute alloreactive immune responses 8.15
Tissue-resident memory T cells mediate immune homeostasis in the human pancreas through the PD-1/PD-L1 pathway 8.12
High-Throughput Screening of Human Induced Pluripotent Stem Cell Cardiomyocytes Predicts Tyrosine Kinase Inhibitor Cardiotoxicity 8.1
Tyrosine Kinase Inhibitor Cardiotoxicity 8.1
Identification of mRNAs with reduced ribosomal loading upon knock-down of translation factor DAP5 from hESCs. 8.02
Specific modulation of HIV RNA splicing and upregulation of anti-inflammatory miR-124 by the new drug candidate ABX464 8.02
Mining the stiffness-sensitive transcriptome in human vascular smooth muscle cells identifies long non-coding RNA stiffness regulators 7.96
A Druggable TCF4- and BRD4-dependent Transcriptional Network Sustains Malignancy in Blastic Plasmacytoid Dendritic Cell Neoplasm (RNA-Seq) 7.94
Novel SF3B1 Deletion Mutations Result in Aberrant RNA Splicing in CLL Patients 7.92
Chromatin accessibility landscape upon induction of Msgn1, Pax3 and Myf5 in mesodermal cells and identification of conserved Pax3 binding sites and target genes during skeletal myogenesis 7.9
MiR-CLIP capture of a miRNA targetome uncovers a lincRNA H19-miR-106a interaction 7.77
Mapping interactions for the TNIP2 hub protein 7.59
Characterisation of the myeloid differentiation process of human hematopoietic stem cells 7.58
Transcriptomics-based drug repurposing approach identifies novel drugs against sorafenib-resistant hepatocellular carcinoma 7.53
Role of SUMOylation in differential ERα transcriptional repression by SERMs and pure antiestrogens in breast cancer cells 7.42
RNA-seq and flow-cytometry of conventional, scalp, and palmoplantar psoriasis reveal shared and distinct molecular pathways 7.34
Identification of HOXB13 target genes responsive to BET inhibitors 7.25
Adenovirus Small E1A Employs the Lysine Acetylases p300/CBP and Tumor Suppressor Rb to Repress Select Host Genes and Promote Productive Virus Infection 7.25
Adenovirus Small E1A Employs the Lysine Acetylases p300/CBP and Tumor Suppressor Rb to Repress Select Host Genes and Promote Productive Virus Infection [RNA-seq] 7.25
Transcriptome analysis upon C6orf203 silencing 7.21
Whole blood stabilization for the microfluidic isolation and molecular characterization of circulating tumor cells 7.15
MEF2C phosphorylation is required for chemotherapy resistance in acute myeloid leukemia [mutant MEF2C] 7.07
Solid phase chemistry to covalently and reversibly capture thiolated RNA 7.04
Genome-scale identification of transcription factors that mediate an inflammatory network during breast cellular transformation 7.04
RNA-seq during MCF10A-ER-Src cell transformation and upon factor knockdowns 7.04
Impact of GDF15 expression of ovarian cancer cell on stroma and Cisplatin responses 6.99
The MLL-AF9 and MLL-AF4 oncofusion proteins bind a distinct enhancer repertoire and target the RUNX1 program in MLLr AML 6.97
Tracing transcriptome profiles of human oocyte cultured by growth hormone or not in vitro by single cell RNA-seq 6.86
RNA-sequencing of mRNAs from control and CAP-D3 deficient Salmonella infected HT-29 cells 6.82
Combinatorial Reprogramming of Estrogen Signaling by the Nuclear Receptor Family 3C 6.8
Zoledronic acid inhibits NFAT and IL-2 signaling pathways in regulatory T cells and diminishes their suppressive function in patients with metastatic cancer 6.74
Translocation of dense granule effectors across the parasitophorous vacuole membrane in Toxoplasma-infected cells requires the activity of ROP17, a rhoptry protein kinase 6.72
Distinct gene expression profile of Huh7 cell lines stably overexpressing CRABP1 or 2 6.67
RNA sequencing to study transcriptomic changes in DLD-1 (colorectal adenocarcinoma) cells exposed to soft polyacrylamide matrices (~2 kPa and ~55 kPa) for short time scale of 90 minutes 6.66
Expression data from A2780 cells treated with DMSO, Olaparib(Ola), Palbociclib(PD), and their combination (Ola/PD) 6.61
Transcriptomic Dynamics during Differentiation Process of Human Pluripotent Cells into Hepatocyte-like Cells 6.59
RNA-seq analysis of human cardiosphere cells with different tubule supportive potential 6.55
Gene expression profiling of human and murine in vitro muscle differentiation 6.52
Alterations of the MEK/ERK, BMP, and Wnt/b-catenin pathways detected in the blood of individuals with lymphatic malformations 6.51
Remodeling of Ago2-mRNA interactions upon cellular stress reflects miRNA complementarity and correlates with altered translation rates (part 4) 6.38
Remodeling of Ago2-mRNA interactions upon cellular stress reflects miRNA complementarity and correlates with altered translation rates 6.38
Comparative genome-wide analysis of human BM IL3Rα-high precursors show a more MΦ-, DC- and OC committed gene expression profile, as compared to IL3Rα-low precursors 6.35
Aneuploidy-induced cellular stresses limit autophagic degradation. 6.35
Allogeneic mature human dendritic cells generate superior alloreactive regulatory T cells in the presence of IL-15 6.34
Positively selected enhancer elements endow tumor cells with metastatic competence 6.24
An intramolecular salt bridge linking TDP43’s RNA recognition motifs dictates RNA binding, protein stability and TDP43-dependent neurodegeneration 6.23
MiR-CLIP capture of a miRNA targetome uncovers a lincRNA H19-miR-106a interaction [III] 6.19
Sorted MDMs with RFP+GFP+ or RFP+GFP- Mtb 6.12
A systematic analysis of nuclear heat-shock protein 90 identifies a metazoan-specific regulatory module 6.1
Probing the Global Cellular Responses to Lipotoxicity Caused by Saturated Fatty Acids 6.05
Potent antitumor activity of Cabozantinib, a c-MET and VEGFR2 Inhibitor, in a Colorectal Cancer Patient-derived Tumor Explant Model 6.02
Small-molecule-based Human Genome G4 Profiling Reveals Potential Gene Regulation Activity 6.01
Gene-Edited Human Kidney Organoids Reveal Mechanisms of Disease in Podocyte Development 5.96
Expanding the Nucleoside Recoding Toolkit: Revealing RNA Population Dynamics with 6-thioguanisine 5.92
Downregulation of DDX5/DDX17 and REST 5.86
Transcriptomic analysis of acute mitochondrial pyruvate carrier inhibition using UK5099 in ABL prostate cancer cells 5.81
single cell RNA-seq from GM12878 (ENCSR673UIY) 5.76
Monitoring Nivolumab binding as a method to clarify the residual therapeutic effects and to characterize the immune profile in antibody bound T cells in previously treated non-small cell lung cancer patients 5.74
Determination of tRNA aminoacylation levels by high throughput sequencing 5.73
RNA deep sequencing to compare genome-wide differences between PRMT5/knockdown and control AML cells 5.7
AhR activity directs BRAF inhibitors resistance in metastastic melanoma 5.64
Analysis of chromosomal aberrations and recombination by allelic bias in RNA-Seq 5.61
ARID1A and ARID1B loss in HCT116 and TOV21G cells 5.58
Transcriptomic changes mediated by β-amyloid in human aortic endothelial cells (HAOEC) 5.58
Sirt6 Oncogene Mediates PI3K/Akt Signaling Activation in Diffuse Large B-Cell Lymphoma 5.54
Ewing sarcoma resistance to SP-2509 is not mediated through KDM1A/LSD1 mutation II 5.51
Human cells contain natural double-stranded RNAs with potential regulatory capacity 5.38
Comparing oestrogen-responsive genes in endometrial and breast cancer cell lines 5.34
RNA-seq reveals abundant circRNA, lncRNA and mRNA in blood exosomes of patients with colorectal carcinoma 5.22
Ewing sarcoma resistance to SP-2509 is not mediated through KDM1A/LSD1 mutation I 5.19
FOXP2's impact on the primate transcriptome 5.18
RNA-seq reveals abundant circRNA, lncRNA and mRNA in blood exosomes of patients with pancreatic carcinoma 5.08
Blocking expression of inhibitory receptor NKG2A overcomes tumor resistance to NK cells 5.06
Global response to chemotherapy-induced apoptosis 4.97
The p30 isoform of CEBPA uncovers a silent enhancer to drive the expression of the tumor promotive factor CD73 in CEBPA mutant AML 4.94
Transcriptome profile of HepG2-expressing ATP7B-H1069Q (liver hepatocellular cells) exposed to JNK or p38 Inhibitor 4.93
Transcriptomic analysis of iPSC and ESC challenged with atmospheric or physiological oxygen 4.9
Studying the selectivity of a targeted small molecule degrading a hypoxia-associated non-coding RNA 4.87
MEF2C phosphorylation is required for chemotherapy resistance in acute myeloid leukemia 4.81
Abnormal RNA splicing and genomic instability after induction of DNMT3A mutations by CRISPR/Cas9 gene editing 4.62
Abnormal RNA splicing and genomic instability after induction of DNMT3A mutations by CRISPR/Cas9 gene editing [RNA-Seq] 4.62
N6-methyladenine DNA Modification in Glioblastoma 4.41
N6-methyladenine DNA Modification in Glioblastoma [RNA-seq] 4.41
Ro60-knockout cells 4.3
EWS-Fli and LNC regulated genes in comparison to GFP samples 4.26
Transcriptome landscape of HeLa response upon triamcinolone acetonide 4.23
Effect of Polybrominated diphenyl ethers (PBDEs) on gene expression of MCF7 cells 4.09
Newly defined ABCB5+ dermal mesenchymal stem cells promote healing of chronic iron overload wounds via secretion of interleukin-1 receptor antagonist 4.0
Genome-wide transcriptome analysis of organotypic rafts derived from human papillomavirus type 16 infected primary keratinocytes [3D raft] 3.78
Copper Regulation of HIF-1 Transcription Activity 3.76
Copper Regulation of HIF-1 Transcription Activity [RNA-seq] 3.76
Co-Stimulation–Induced AP-1 Activity is Required for Chromatin Opening During T Cell Activation [RNA-seq] 3.71
Co-Stimulation–Induced AP-1 Activity is Required for Chromatin Opening During T Cell Activation. 3.71
CDK12 inhibition in Hep3B, Huh7 and SNU449 cells 3.7
IL-10 dysregulation in acute mountain sickness revealed by transcriptome analysis 3.68
Next Generation Sequencing (RNA-Sequencing) for the analysis of RUNX3 targets in H460, H460-ERT2-RUNX3 WT and H460-ERT2-RUNX3 MT(K94/171R mutation) 3.65
Genome-wide mapping of DROSHA cleavage sites on primary microRNAs and novel substrates 3.56
Genome-wide mapping of DROSHA cleavage sites on primary microRNAs and novel substrates [RNA-seq] 3.56
Effect of from Human Umbilical Vein Endothelial Cells 3.52
Global host gene expression changes in KSHV+ PEL cells upon KSHV reactivation 3.47
Structure and degradation of circular RNAs regulate PKR activation in innate immunity 3.47
Functional Significance of U2AF1 S34F Mutation in Lung Adenocarcinomas 3.46
miR-93 Targets in Human Endothelial Cells 3.44
Transcriptional regulation of autophagy-lysosomal function in BRAF-driven melanoma progression and chemoresistance 3.36
Integrated high-throughput screen to identify novel treatment leads for pediatric acute myeloid leukemia (AML) 3.29
Leucegene: ALL sequencing 3.27
Genome-wide Dose-dependent Inhibition of Histone Deacetylases Reveals Their Roles in Enhancer Remodeling and Suppression of Oncogenic Super-enhancers 3.26
Coordinated regulation of synthesis and stability of RNA during the acute TNF-induced proinflammatory response 3.26
Comparative Analysis of Cas9 Activators Across Multiple Species 3.22
JAG1 Mediated Notch Signaling Regulates Secretory Cell Differentiation of the Human Airway Epithelium 3.0
Profiling of escape kinetics of viruses subjected to RNAi 2.98
The cytokine environment influence on human skin-derived T cells 2.84
Transcriptional changes in pancreatic cancer cells associated with gemcitabine resistance 2.83
Transcriptomics analysis of gene expression in normal and METTL3 or WTAP deficient Human HeLa cells 2.83
A comprehensive gene expression analysis identifies novel immune signatures in cesarean-born infants 2.77
Prospective Isolation and Comparison of Human Germinal Matrix and Glioblastoma EGFR+ Populations with Stem Cell Properties 2.74
Induction of human regulatory innate lymphoid cells from group 2 innate lymphoid cells by retinoic acid 2.74
RNA deep sequencing analysis of glioma stem cells(GSCs) and non-GSCs 2.7
Expression profiling of pancreatic adenocarcinoma and ductal adenocarcinoma cell lines. 2.66
Pan-cancer transcriptomic analysis associates long non-coding RNAs with key mutational driver events 2.58
Microenvironmental-derived Regulation of HIF-Signaling Drives Transcriptional Heterogeneity in Glioblastoma Multiforme 2.5
CD8+ T cells regulate tumor ferroptosis during cancer immunotherapy 2.47
GATA2 is Dispensable for Generation of Hemogenic Endothelium But Required for Endothelial-to-Hematopoietic Transition 2.36
Patient-derived organoids (PDOs) model treatment response of metastatic gastrointestinal cancers. 2.36
RNA-seq transcriptonal profiling in human K562 cells with or without dCas9 and sgRNAs 2.35
In situ CAPTURE of chromatin interactions by biotinylated dCas9 2.35
Long-term in vitro expansion of epithelial stem cells enabled by pharmacological inhibition of PAK1-ROCK-Myosin II and TGF-β signaling 2.31
Long-term in vitro expansion of epithelial stem cells enabled by pharmacological inhibition of PAK1-ROCK-Myosin II and TGF-β signaling (RNA-seq) 2.31
The transcription and translation landscapes during human cytomegalovirus infection reveal novel host-pathogen interactions 2.31
RNA-seq of MDA-MB-231 cells with TET1 knockout 2.25
Human Treg NaCl stimulation 2.23
Pseudouridylation of tRNA-derived fragments steers translation control in stem cells [Polysome-Seq] 2.18
TSLP acts on neutrophils to drive complement-mediated killing of methicillin-resistant Staphylococcus aureus 2.17
Single-cell transcriptome of human epithelial cells reveals novel insights into early innate immune responses to influenza virus and viral antagonism 2.17
Single-cell Transcriptomics reveals multi-step adaptations to endocrine therapy 2.14
Transcriptome-analysis of patient-derived normal and ulcerative colitis intestinal epithelial organoids 2.13
An interaction with Ewing's sarcoma breakpoint protein EWS defines the specific oncogenic mechanism of ETS factors rearranged in prostate cancer 2.05
Flura-seq identifies organ-specific adaptations in metastasis-initiating cells 1.99
Role of OSGIN1 in Mediating Smoking-induced Autophagy in the Human Airway Epithelium 1.96
Role of OSGIN1 in Mediating Smoking-induced Autophagy in the Human Airway Epithelium [RNA-Seq] 1.96
RNA sequencing data of whole blood cells of normal glucose tolerant (NGT) and gestational diabetes (GDM) pregnant women 1.94
Smoking Dysregulates the Human Airway Basal Cell Transcriptome at COPD-linked Risk Locus 19q13.2 1.94
RNA sequencing of isogenic BRCA2 haploinsufficient vs. wild-type T-ALL cells 1.93
Identification of ADAR1 adenosine deaminase dependency in a subset of cancer cells 1.83
Gene expression profiling by RNA-seq in hTert-HME1 cell line treated with control or BRCA2 siRNAs and grown with or without EGF (epithelial growth factor) II 1.81
Time-Resolved Proteomics Extends Ribosome Profiling-Based Measurements of Protein Synthesis Dynamics 1.76
Identifying transcripts that are transcriptinoally regulated by CBFB and RUNX1 using RNAseq 1.75
Genome-wide effect of inhibition of glutamine transporter ASCT2 in PC-3 cells by BenSer or GPNA 1.71
Transposon-based construction of strand-specific RNA-seq libraries 1.66
Analyses of T-ALL (COG study) 1.6
RNA sequencing of T-ALL (COG study) 1.6
GRO-seq from HCT116, MCF7 and SJSA cell lines treated with DMSO and Nutlin 1.59
Identification of a core p53 transcriptional program with highly fractionated tumor suppressive activity 1.59
Human Treg IL-12 stimulation 1.58
Analysis of gene expression in primary human foreskin keratinocytes +/- HPV16 E7 or PTPN14 knockout 1.58
A novel Menin-MLL inhibitor induces specific chromatin changes and eradicates disease in models of MLL-rearranged leukemia [RNA-Seq II] 1.55
Finding missing proteins from epigenetically manipulated human cells 1.45
Xrn2 accelerates termination by RNA polymerase II, which is underpinned by CPSF73 activity 1.44
RNAseq of cell lines with knocked in ESR1 mutations 1.41
MicroRNA-28 replacement for non-Hodgkin lymphoma therapy 1.39
Maternal-biased H3K27me3 correlates with paternal-specific gene expression in the human morula 1.39
Transcriptome analysis of the HepG2 cells expressing hepatic transcription factors 1.36
RNA-Seq analysis of JIB-04 effects on global cellular transcription and HIV in 2D10 T cells 1.3
The Polycomb Repressor Complex 1 Drives Double-Negative Prostate Cancer Metastasis by Coordinating Stemness and Immune Suppression 1.25
mRNA gene expression profiling in a human AML cell line treated with small molecule inhibitors that impact different RNA polymerase transcription complexes, or their combination, in comparison to a global DNA-damaging anthracycline compound 1.22
YTHDF1 Amplifies Wnt/β-Catenin Signaling to Promote Intestinal Stemness 1.18
The Regulation of IFN Type I Pathway Related Genes RSAD2 and ETV7 Specifically Indicate Antibody-Mediated Rejection After Kidney Transplantation 1.17
SPOP mutation confers intrinsic BET inhibitor resistance in prostate cancer 1.09
RNA-seq analysis of BAP1-depleted uveal melanoma cells 1.03
Wide-scale analysis of alternative polyadenylation (APA) associated with proliferation and transformation using 3'-Seq 1.03
SREBP1 drives Keratin 80-dependent cytoskeletal changes and invasive behavior in endocrine resistant ERα breast cancer 1.02
Therapy-induced hypoxia contributes to AML drug-resistance through BMX Kinase upregulation 0.98
Exogenous rescue of KLHL9 in SF210 cell line 0.97
Transcriptome landscape of human primary monocytes response upon different ligand glucocorticoids 0.94
Effects of darunavir upon gene expression in kidney tubular cells after transduction with HIV or EGFP-control lentivirus 0.8
RNA-Seq data of NCI-H82 cells expressing a Dox-On pRB (pTripZ RB1) grown in the presence or absence of DOX and then treated with vehicle or AZD2811. 0.72
RNA sequencing analysis of human podocytes reveals glucocorticoid regulated gene networks targeting non-immune pathways 0.67
RNA sequencing reveals levamisole target genes PTPRZ1 and MDK and their links to interferon pathway in human podocytes 0.66
RNA-sequencing analysis of glucose and acetate regulated transcripts in glioblastoma cells 0.65
Aberrant splicing in B-cell acute lymphoblastic leukemia [B-ALL] 0.62
Profiling premalignant lesions in lung squamous cell carcinomas identifies mechanisms involved in stepwise carcinogenesis 0.58
iPSC derived motor neuron cultures from C9ORF72 carriers 0.51
6mer seed toxicity in viral microRNAs 0.49
m6A-RNA mapping, SND1-RNA binding profile mapping and SND1-depletion in KSHV-infected B-lymphocytes 0.45
Exploring the gene expression profile upon FXR1 knockdown in H358 cells using RNA-seq 0.41
Host transcriptome analysis of Aspergillus fumigatus infection in Airway Epithelial Cells 0.36
Dermal endothelial cells of type 2 diabetic patients 0.36
HIV Reprograms Human Airway Basal Stem/Progenitor Cells to Acquire a Tissue Destructive Phenotype 0.35
Functional genomic analysis of the haploinsufficient tumor suppressor, CUX1 0.34
RNA-Seq of SHEP TET21N cells upon Doxorubicin treatment 0.34
Cell cycle dynamics of human pluripotent stem cells primed for differentiation 0.34
Identification of long noncoding RNAs in T-ALL cell lines 0.29
NF-κB p65 dimerization and DNA-binding is important for inflammatory gene expression 0.28
Genetic and Epigenetic Landscapes of Laterally Spreading Tumors of the Colorectum 0.24
Determining mRNA half-lives on a transcriptome-wide scale 0.13
Expression of long non-coding RNAs in autoimmunity and linkage to enhancer function and autoimmune disease risk genetic variants 0.11
Targeting Spt5-Pol II small-molecule inhibitors uncouple distinct activities and reveal additional regulatory roles 0.07
Stapled peptide inhibitors of RAB25 target context-specific phenotypes in cancer 0.07
Total RNA-Seq data from leukemic patients with complex structural variants 0.03
Extracellular matrix (ECM) stiffness and collagen-1 (col-1) responsive genes in 3D cultured mammary epithelial cells 0.03
Transcriptome-profiling (RNA-seq) and Ribosome-profiling (Ribo-seq) in proliferation, quiescence, senescence and transformed states. 0.03
Genome-wide search for differentially expressed RNAs responsible for the effects induced by Ebola virus replication and transcription 0.02
Transcriptional profiling of growing and senescent WT and IL-1R-depleted IMR90 cells 0.01


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation